Trump’s plan to levy duties on pharma violates WTO rules, but there is no recourse as the trade regulator is dysfunctional

As China’s low-cost AI breakthrough reshapes global competition, India must rethink its approach to innovation challenges in the race for...

Trump's aide Vivek Ramaswamy has a risky agenda on his side; he wants to gut the Food and Drug Administration to make drug approvals easy and quick

Africa’s mpox epidemic stems from delayed responses, neglect of its health risks and the stark vaccine apartheid

India’s top drug firms oppose the move to allow government drug stores to sell generic substitutes, but what is the real reason?

Deep political rifts at WHO have left a critical pandemic treaty hanging in limbo as rich nations baulk at equitable vaccine sharing

Despite strong pleas, the ruling dispensation has changed the rules to impose a cost on those who challenge faulty patents

Making universities the hub of innovation and churning out scientists adept in frontier technology has put China at the top in terms of technological...

Frugal innovation is the new concept that companies are adopting to take technology to developing countries

Mahatma Gandhi’s works have been available freely thanks to his copyright philosophy, but not those of Martin Luther King Jr

Bringing medicines into the global intellectual property regime was a triumph of corporate skulduggery led by Pfizer

Dilution of biological conservation rules and lax enforcement of forest laws are giving free rein to the drug industry and trade